Solstice Advanced Materials Inc. Common Stock (SOLS) Stock Analysis
P/E 37.74×· 5Y range 32.57–59.55×· bottom 7% of history
Sector: Basic Materials · Industry: Chemicals & Allied Products
AnalystsStrong Buy13 analystsStrengths
- ✓Piotroski F-Score 7/9 — high earnings quality
- ✓ROE 15.9% — efficient capital deployment
- ✓Interest coverage 1935.8× — debt well covered
- ✓P/E 37.7× at bottom 7% of 5-year history
Risks
- ⚠Altman Z 1.7 — distress-zone balance sheet
- ⚠Beneish M 6.15 — earnings-manipulation flag
- ⚠2 loss-making years in recent history
Price History
5-Year Weekly Candlestick Chart
Profile
growth and earnings quality lag behind.
How is each axis scored?
- Valuation62/100 · Moderate
- P/E vs own history (7th pct)25/25
- FCF yield (1.3%)5/25
- P/S (2.3x)20/25
- EV/EBIT (15.8x)12/25
- Growth25/100 · Weak
- Revenue CAGR (n/a)0/25
- Net income CAGR (n/a)0/25
- EPS CAGR 5Y (n/a)0/25
- Fwd implied growth (92.5%)25/25
- Profitability73/100 · Moderate
- ROIC (18.2%)20/25
- ROE (15.9%)20/25
- Net margin (6.1%)13/25
- Operating margin (16.6%)20/25
- Financial Health59/100 · Moderate
- Altman Z (1.69)10/25
- Current ratio (1.43)12/25
- Interest coverage (1935.8x)25/25
- Net cash / debt (D/A 23%)12/25
- Quality37/100 · Weak
- Piotroski F (7/9)22/25
- Beneish M (6.15)0/25
- FCF conversion (50%)15/25
- Margin stability (σ 878.4%)0/25
About Solstice Advanced Materials Inc. Common Stock
Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell. Show more
It sells chemicals and materials to a wide range of end markets. Its largest product category is refrigerants used in heating, ventilation and air conditioning systems, and autos, where Solstice sells low global warming potential refrigerants. The company also sells materials used for building and construction, semiconductor production, healthcare packaging, and defense. Additionally, Solstice runs the only US uranium conversion business currently in operation.
Headquarters: MORRIS PLAINS, NJ · Employees: 4,400 · Website ↗
Insider Transactions
Recent SEC Form 4 filings
- BuyGrant / award · filed 2026-09-14+9 sh2026-09-10
- BuyGrant / award · filed 2026-09-14+12 sh2026-09-10
- BuyGrant / award · filed 2026-09-14+4 sh2026-09-10
- BuyGrant / award · filed 2026-09-14+7 sh2026-09-10
- BuyGrant / award · filed 2026-09-14+2 sh2026-09-10
+3 more recent filings
Key Metrics
Financial snapshot — pillar inputs plus per-share and market context
Valuation
62BP/E (TTM)37.7xD
Grade D: ExpensivePrice / TTM EPS (own statements) — vs own 5Y history: 32.6x–59.6x · 7th pct
P/FCF29.3xB
Grade B: FairPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield1.3%C
Grade C: LowTTM FCF / Market Cap — vs own 5Y history: 0.8%–1.5% · 94th pct
P/S (TTM)2.30xB
Grade B: FairPrice / TTM Revenue (own statements) — vs own 5Y history: 2.0x–3.6x · 6th pct
EV/EBIT15.8xB
Grade B: FairEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 14.1x–23.9x · 6th pct
EV/Sales2.6xB
Grade B: FairEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E19.6xB
Grade B: FairPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio6.00xC
Grade C: ExpensivePrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio—
Finnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield—
TTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio632.9%D
Grade D: UnsustainableDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
73B+ROIC18.2%A
Grade A: MoatNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE15.9%C
Grade C: AverageReturn on Equity. Neg. equity = heavy buybacks
ROA3.7%D
Grade D: WeakReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin6.1%C
Grade C: AverageNet Income / Revenue
Operating Margin16.6%C
Grade C: AverageTTM EBIT / TTM Revenue
Gross Margin32.2%C
Grade C: AverageGross Profit / Revenue
FCF Margin3.1%D
Grade D: LowFCF / Revenue
True FCF Margin2.4%D
Grade D: LowTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Financial Health
59CAltman Z-Score1.69D
Grade D: DistressBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio1.43xC
Grade C: OkCurrent Assets/Liabilities
Quick Ratio0.98xC
Grade C: Ok(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage1935.8xA
Grade A: StrongEBIT/Interest. >10 Strong
Debt Repayment11.1yD
Grade D: SlowYears to repay net debt via FCF
Net Debt/EBIT2.0xC
Grade C: MedLeverage. <2x Low, >4x High
Debt/Equity1.32xC
Grade C: MedDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt0.33xC
Grade C: PartialCash covers how much of total debt. >1 = could repay all debt from cash
Growth
25ERevenue CAGR—
Compound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR—
Compound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)—
Compound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth92.5%A
Grade A: HighImplied 1Y EPS growth from forward P/E vs our TTM EPS. Sparse — only where forward estimates exist
Dilution (5Y)—
Share count change over 5Y
SBC / Net Income11.4%C
Grade C: MedStock-based comp/Net income. >30% = dilution risk
SBC / Revenue0.7%A
Grade A: LowTTM stock-based comp / TTM Revenue
Quality
2/3 Loss Years37DPiotroski F-Score7/9A
Grade A: StrongFinancial strength 0–9. >7 Strong
Beneish M-Score6.15D
Grade D: RiskyEarnings manipulation risk. < -2.22 Safe
FCF Conversion50.2%C
Grade C: AverageFCF / Net Income
Margin Stability878.4%D
Grade D: VolatileEBIT margin std deviation. Lower = stable
Capex / Revenue8.6%C
Grade C: AverageTTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.69xC
Grade C: AverageRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
More metrics — Per Share, Balance Sheet, MarketHide additional metrics
Per Share
EPS (TTM)$1.49
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$3.36
Cash & short-term investments per share (Finnhub)
Book Value / Share$8.89
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt$1.97B
Total debt obligations (short + long term)
Cash & Equiv.$642.00M
Cash and short-term investments
Net Debt$1.32B
Total Debt minus Cash. Negative = Net Cash position
Total Equity$1.49B
Shareholders' equity (book value)
Asset / Liability1.34xC
Grade C: AdequateTotal Assets / Total Liabilities
Market
Market Cap$8.92B
Current Market Capitalization
Beta0.20B
Grade B: DefensivePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
Takeaway
Takes ~11.1 years to repay net debt from free cash flow. · Current P/E of 37.7x sits at the 7th percentile of its historical range.
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Mar 2026 · Ratio snapshot Sep 26, 2026
Key Insights: Solstice Advanced Materials Inc. Common Stock (SOLS)
Solstice Advanced Materials Inc. Common Stock meets 7 of 9 Piotroski F-Score criteria, placing its fundamental strength in the top tier of US-listed stocks. Altman Z-Score of 1.69 is below the 1.81 distress threshold — an elevated financial-risk flag. Beneish M-Score of 6.15 is above the −1.78 flag threshold, a signal that reported earnings warrant closer scrutiny.
- Takes ~11.1 years to repay net debt from free cash flow.
- Solstice Advanced Materials Inc. Common Stock posted a net loss in 2 of 3 available completed fiscal years (2020–2025).
See how SOLS ranks on the Capex Tracker — top 50 capital spenders compared.
No significant market moves for SOLS in the last 30 days.
See SOLS move history →Frequently Asked Questions about SOLS
Is SOLS stock a buy right now?
PreMarketPrice's quantitative model rates Solstice Advanced Materials Inc. Common Stock's financial health at 59/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is SOLS stock overvalued?
Solstice Advanced Materials Inc. Common Stock trades at a trailing P/E of 37.7 and our valuation score rates it 62/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does Solstice Advanced Materials Inc. Common Stock report earnings?
No confirmed earnings date is currently scheduled for SOLS. The Earnings section lists recent reports and updates as dates are announced.
What sector does Solstice Advanced Materials Inc. Common Stock operate in?
Solstice Advanced Materials Inc. Common Stock operates in the Basic Materials sector, within the Chemicals & Allied Products industry. The Related Stocks section lists sector peers for comparison.
What does Solstice Advanced Materials Inc. Common Stock do?
Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell.
About Solstice Advanced Materials Inc. Common Stock (SOLS) Stock
Solstice Advanced Materials Inc. Common Stock (SOLS) is a US-listed stock operating in the Basic Materials sector, specifically the Chemicals & Allied Products industry. Real-time pricing data for Solstice Advanced Materials Inc. Common Stock is available on this page with a market capitalization of $8.9 billion. The financial health score for SOLS is 59/100, which indicates moderate financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for SOLS stock.
SOLS Stock Analysis & Key Metrics
On PreMarketPrice, you can track Solstice Advanced Materials Inc. Common Stock (SOLS) across multiple dimensions:
- Pre-market price & movement: Real-time SOLS stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for SOLS with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for Solstice Advanced Materials Inc. Common Stock across multiple reporting periods.
- Financial health score: A composite score of 59/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for SOLS.
- Sector peers: Compare SOLS against 10 other basic materials stocks on key financial metrics.
Is SOLS a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate Solstice Advanced Materials Inc. Common Stock (SOLS) as an investment. The financial health score of 59/100 suggests moderate financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Solstice Advanced Materials Inc. Common Stock (SOLS) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.